BCM
STLNW

Basso Capital Management’s Starling Oncology Warrant STLNW Stock Holding History

Basso Capital Management’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-26,160
Closed -$38K – 190
2020
Q2 		$38K Buy
+26,160
New +$37.5K 0.01% 158

Other funds holding STLNW

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Basso Capital Management's STLNW Position: Q3 2020 in Review

Basso Capital Management sold out of Starling Oncology Warrant (STLNW) in Q3 2020, closing a stake of 26,160 shares — an estimated $38K sold.

Basso Capital Management first reported a position in STLNW in Q2 2020 and held it in 1 quarter. The position peaked at $38K in Q2 2020. 22 funds tracked by Wall St. Rank hold STLNW as of Q3 2020.

  • Basso Capital Management reported no remaining Starling Oncology Warrant position as of Q3 2020 after selling out during the quarter.
  • Basso Capital Management sold 26,160 Starling Oncology Warrant shares in Q3 2020, an estimated $38K.
  • Basso Capital Management first reported a position in Starling Oncology Warrant in Q2 2020 and held it in 1 quarter.
  • Basso Capital Management's Starling Oncology Warrant position peaked at $38K in Q2 2020.
  • 22 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q3 2020.

Based on Basso Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.